Crossmark

Decrease in inflammatory biomarker concentration by intervention with selenium and coenzyme Q10: a subanalysis of osteopontin, osteoprotergerin, TNFr1, TNFr2 and TWEAK

Crossref DOI link: https://doi.org/10.1186/s12950-019-0210-6

Published Online: 2019-03-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alehagen, Urban

Alexander, Jan

Aaseth, Jan

Larsson, Anders
License Information

Text and Data Mining valid from 2019-03-18
More Information

Article History

Received: 13 February 2019

Accepted: 12 March 2019

First Online: 18 March 2019

Ethics approval and consent to participate

: The study protocol has previously been published [CitationRef removed]. The study was approved by the Regional Ethical Committee in Linköping (Diary no. 03–176) and conforms to the ethical guidelines of the 1975 Declaration of Helsinki.The intervention study was registered at ExternalRef removed, and has the identifier NCT01443780.Written, informed consent was obtained from all patients.

: Informed consent was obtained from each patient.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below